Literature DB >> 19472201

Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality.

Aaron R Folsom1, Joseph A C Delaney, Pamela L Lutsey, Neil A Zakai, Nancy S Jenny, Joseph F Polak, Mary Cushman.   

Abstract

To examine the associations of three understudied hemostatic factors--D-dimer, factor VIII(c), and plasmin-antiplasmin (PAP) complex--with incident cardiovascular disease (CVD) and all cause mortality in the Multiethnic Study of Atherosclerosis cohort. Hemostatic factors were measured at baseline in 45-84-year-old patients (n = 6,391) who were free of clinically recognized CVD. Over 4.6 years of follow-up, we identified 307 CVD events, 207 hard coronary heart disease events, and 210 deaths. D-dimer, factor VIII(c), and PAP were not associated with CVD incidence after adjustment for other risk factors. In contrast, each factor was associated positively with total mortality, and D-dimer and factor VIII(c) were associated positively with cancer mortality. When modeled as ordinal variables and adjusted for risk factors, total mortality was greater by 33% (95% CI 15-54) for each quartile increment of D-dimer, 26% (11-44) for factor VIIIc, and 20% (4-38) for PAP. This prospective cohort study did not find D-dimer, factor VIII(c), or PAP to be risk factors for CVD. Instead, elevated levels of these three hemostatic factors were associated independently with increased risk of death. Elevated D-dimer and factor VIII(c) were associated with increased cancer death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19472201      PMCID: PMC2950108          DOI: 10.1002/ajh.21429

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  24 in total

1.  Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D Lowe
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

2.  Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway.

Authors:  G J Miller; K A Bauer; D J Howarth; J A Cooper; S E Humphries; R D Rosenberg
Journal:  J Thromb Haemost       Date:  2004-12       Impact factor: 5.824

3.  Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture.

Authors:  Gordon D O Lowe
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

4.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

Authors:  John Danesh; Sarah Lewington; Simon G Thompson; Gordon D O Lowe; Rory Collins; J B Kostis; A C Wilson; A R Folsom; K Wu; M Benderly; U Goldbourt; J Willeit; S Kiechl; J W G Yarnell; P M Sweetnam; P C Elwood; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; F Haverkate; M P M de Maat; F G R Fowkes; A J Lee; F B Smith; V Salomaa; K Harald; R Rasi; E Vahtera; P Jousilahti; J Pekkanen; R D'Agostino; W B Kannel; P W F Wilson; G Tofler; C L Arocha-Piñango; A Rodriguez-Larralde; E Nagy; M Mijares; R Espinosa; E Rodriquez-Roa; E Ryder; M P Diez-Ewald; G Campos; V Fernandez; E Torres; R Marchioli; F Valagussa; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; P Cremer; D Nagel; J D Curb; B Rodriguez; K Yano; J T Salonen; K Nyyssönen; T-P Tuomainen; B Hedblad; P Lind; H Loewel; W Koenig; T W Meade; J A Cooper; B De Stavola; C Knottenbelt; G J Miller; J A Cooper; K A Bauer; R D Rosenberg; S Sato; A Kitamura; Y Naito; T Palosuo; P Ducimetiere; P Amouyel; D Arveiler; A E Evans; J Ferrieres; I Juhan-Vague; A Bingham; H Schulte; G Assmann; B Cantin; B Lamarche; J-P Després; G R Dagenais; H Tunstall-Pedoe; M Woodward; Y Ben-Shlomo; G Davey Smith; V Palmieri; J L Yeh; A Rudnicka; P Ridker; F Rodeghiero; A Tosetto; J Shepherd; I Ford; M Robertson; E Brunner; M Shipley; E J M Feskens; D Kromhout; A Dickinson; B Ireland; K Juzwishin; S Kaptoge; S Lewington; A Memon; N Sarwar; M Walker; J Wheeler; I White; A Wood
Journal:  JAMA       Date:  2005-10-12       Impact factor: 56.272

5.  Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.

Authors:  Ann Smith; Chris Patterson; John Yarnell; Ann Rumley; Yoav Ben-Shlomo; Gordon Lowe
Journal:  Circulation       Date:  2005-11-15       Impact factor: 29.690

6.  Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.

Authors:  A Rumley; G D Lowe; P M Sweetnam; J W Yarnell; R P Ford
Journal:  Br J Haematol       Date:  1999-04       Impact factor: 6.998

7.  Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.

Authors:  N A Zakai; R Katz; N S Jenny; B M Psaty; A P Reiner; S M Schwartz; M Cushman
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

8.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.

Authors:  M Cushman; R N Lemaitre; L H Kuller; B M Psaty; E M Macy; A R Sharrett; R P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

9.  Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women.

Authors:  P A Sakkinen; M Cushman; B M Psaty; B Rodriguez; R Boineau; L H Kuller; R P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

Review 10.  Pathogenesis, clinical and laboratory aspects of thrombosis in cancer.

Authors:  Massimo Franchini; Martina Montagnana; Giovanni Targher; Franco Manzato; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2007-03-31       Impact factor: 5.221

View more
  35 in total

Review 1.  Cardiovascular implications from untreated human immunodeficiency virus infection.

Authors:  Jason V Baker; Jens D Lundgren
Journal:  Eur Heart J       Date:  2011-01-12       Impact factor: 29.983

2.  Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of Atherosclerosis.

Authors:  M K Shea; M Cushman; S L Booth; G L Burke; H Chen; S B Kritchevsky
Journal:  Thromb Haemost       Date:  2014-05-22       Impact factor: 5.249

3.  Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study.

Authors:  Ehsan Motavaf; Kåre Gotschalck Sunesen; Mogens Tornby Stender; Ole Thorlacius-Ussing
Journal:  Int J Colorectal Dis       Date:  2014-08-23       Impact factor: 2.571

4.  Coagulation factor VIII levels are associated with long-term survival - interactions with gender in a large hospital-based cohort.

Authors:  Florian M Kovar; Claudia L Marsik; Christian Joukhadar; Thomas Perkmann; Helmuth Haslacher; Thomas Schickbauer; Paul A Kyrle; Oswald F Wagner; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2010-06-25       Impact factor: 1.704

5.  Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Kwok-Leung Ong; Jingzhong Ding; Robyn L McClelland; Bernard M Y Cheung; Michael H Criqui; Philip J Barter; Kerry-Anne Rye; Matthew A Allison
Journal:  Atherosclerosis       Date:  2015-01-31       Impact factor: 5.162

6.  Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.

Authors:  Laura W Musselwhite; Virginia Sheikh; Thomas D Norton; Adam Rupert; Brian O Porter; Scott R Penzak; Jeff Skinner; JoAnn M Mican; Colleen Hadigan; Irini Sereti
Journal:  AIDS       Date:  2011-03-27       Impact factor: 4.177

7.  Association of markers of hemostasis with death in HIV-infected women.

Authors:  Elizabeth Kiefer; Donald R Hoover; Qiuhu Shi; Mark H Kuniholm; Michael Augenbraun; Mardge H Cohen; Elizabeth T Golub; Robert C Kaplan; Chenglong Liu; Marek Nowicki; Phyllis C Tien; Russell P Tracy; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

8.  Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.

Authors:  Álvaro H Borges; Jemma L O'Connor; Andrew N Phillips; James D Neaton; Birgit Grund; Jacqueline Neuhaus; Michael J Vjecha; Alexandra Calmy; Kersten K Koelsch; Jens D Lundgren
Journal:  J Infect Dis       Date:  2016-04-30       Impact factor: 5.226

9.  Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients.

Authors:  Jason V Baker; Katherine Huppler Hullsiek; Robert L Bradford; Rachel Prosser; Russell P Tracy; Nigel S Key
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

10.  Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?

Authors:  Brian B Hart; Anna D Nordell; Jason F Okulicz; Adrian Palfreeman; Andrzej Horban; Eynat Kedem; Jacqueline Neuhaus; David R Jacobs; Daniel A Duprez; James D Neaton
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.